Skip to main content

Immunome Inc.

IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001472012

In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 7 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Immunome Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of IMNM: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders1211143+23
Shares53.3M186.1K76.9M+23.8M (+44.8%)
Value$566.3M$1.98M$518.4M−$45.9M (−8.1%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (40)

Institutions that held Immunome Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to IMNM in Q1 2025
InstitutionSharesValue% of portfolio
Caption Management, LLC750,000$5.05M0.23%
Driehaus Capital Management LLC610,551$4.11M0.04%
Schroder Investment Management Group263,867$1.84M0.00%
Exome Asset Management LLC263,841$1.78M1.59%
Nuveen, LLC239,940$1.61M0.00%
Readystate Asset Management LP224,240$1.51M0.08%
Velan Capital Investment Management LP153,500$1.03M1.06%
ExodusPoint Capital Management, LP102,153$687.0K0.01%
Zimmer Partners, LP100,000$673.0K0.01%
Prelude Capital Management, LLC80,742$543.4K0.05%
Main Management ETF Advisors, LLC75,696$509.0K0.03%
Freestone Capital Holdings, LLC61,681$415.1K0.02%
Lido Advisors, LLC53,000$356.7K0.00%
Dark Forest Capital Management LP46,044$309.9K0.01%
Private Capital Advisors, Inc.38,501$259.1K0.03%
Walleye Capital LLC37,114$249.8K0.00%
Fox Run Management, L.L.C.30,220$203.4K0.03%
SG Americas Securities, LLC26,599$179.0K0.00%
Man Group plc22,545$151.7K0.00%
SummitTX Capital, L.P.20,876$140.5K0.01%
Citizens Financial Group Inc20,000$134.6K0.00%
ADAR1 Capital Management, LLC20,000$134.6K0.03%
Virginia Retirement Systems Et Al19,900$133.9K0.00%
CIBC World Markets Corp15,733$105.9K0.00%
Antipodes Partners Ltd14,164$95.3K0.00%
Virtus Investment Advisers, Inc.12,561$84.5K0.02%
Gotham Asset Management, LLC10,200$68.6K0.00%
Pictet Asset Management Holding SA10,181$68.5K0.00%
Coldstream Capital Management Inc1,950$13.1K0.00%
Group One Trading, L.P.1,700$11.4K0.00%
Versant Capital Management, Inc1,170$7.87K0.00%
Allworth Financial LP120$1.02K0.00%
Federation des caisses Desjardins du Quebec141$9490.00%
Jones Financial Companies LLLP120$8390.00%
Lindbrook Capital, LLC102$6860.00%
SRS Capital Advisors, Inc.69$4650.00%
EverSource Wealth Advisors, LLC69$4640.00%
Stephens Consulting, LLC50$3370.00%
US Bancorp21$1410.00%
True Wealth Design, LLC8$540.00%

Sold out (17)

Institutions that held Immunome Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of IMNM in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Qube Research & Technologies Ltd107,794$1.14M
Cubist Systematic Strategies, LLC84,930$902.0K
Virtu Financial LLC45,743$486.0K
Crestline Management, LP24,744$262.8K
Engineers Gate Manager LP22,960$243.8K
Jane Street Group, LLC18,153$192.8K
Squarepoint Ops LLC17,914$190.2K
CI Private Wealth, LLC12,085$128.3K
Verition Fund Management LLC11,175$118.7K
AQR Capital Management LLC10,276$109.1K
Aquatic Capital Management LLC8,935$94.9K
Point72 (DIFC) Ltd7,275$77.3K
Virtus ETF Advisers LLC5,440$57.8K
R Squared Ltd1,410$15.0K
Creative Planning233$2.47K
Parallel Advisors, LLC93$988
Signaturefd, LLC13$138

Not filed for Q1 2025 yet (1)

Institutions that held Immunome Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMNM in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC186,087$1.98M